Angioedema Treatment Market Size and Share Forecast Outlook 2025 to 2035

The Angioedema Treatment Market is estimated to be valued at USD 6.5 billion in 2025 and is projected to reach USD 30.3 billion by 2035, registering a compound annual growth rate (CAGR) of 16.6% over the forecast period.

Quick Stats for Angioedema Treatment Market

  • Angioedema Treatment Market Value (2025): USD 6.5 billion
  • Angioedema Treatment Market Forecast Value (2035): USD 30.3 billion
  • Angioedema Treatment Market Forecast CAGR: 16.6%
  • Leading Segment in Angioedema Treatment Market in 2025: Antihistamines (33.2%)
  • Key Growth Regions in Angioedema Treatment Market: North America, Asia-Pacific, Europe
  • Top Key Players in Angioedema Treatment Market: Shire plc., CSL Limited, Pharming Group NV, Ionis Pharmaceuticals, Inc., iBio Inc., BioCryst Pharmaceuticals, Inc.
Angioedema Treatment Market Market Value Analysis

Angioedema Treatment Market Key Takeaways

Metric Value
Angioedema Treatment Market Estimated Value in (2025 E) USD 6.5 billion
Angioedema Treatment Market Forecast Value in (2035 F) USD 30.3 billion
Forecast CAGR (2025 to 2035) 16.6%

Why is the Angioedema Treatment Market Growing?

The angioedema treatment market is showing consistent growth, driven by the rising prevalence of both hereditary and acquired forms of the condition and the increased focus on early and effective management. Greater awareness among healthcare providers and patients regarding timely diagnosis and treatment has enhanced demand for therapeutic options that provide rapid relief and long-term management. Advancements in drug development, including the refinement of antihistamines, corticosteroids, and newer biologics, are contributing to broader adoption across healthcare systems.

Increased patient visits to emergency care facilities for acute attacks, combined with the availability of specialized treatment centers, are further shaping demand dynamics. Regulatory support for orphan drug designations and ongoing research into targeted therapies are paving the way for innovative solutions.

As healthcare systems place a stronger emphasis on reducing morbidity and improving patient quality of life, the market is positioned for steady expansion Rising investments in clinical trials, pipeline therapies, and improved distribution networks are expected to further strengthen market growth over the coming years.

Segmental Analysis

The angioedema treatment market is segmented by drug class, end use, and geographic regions. By drug class, angioedema treatment market is divided into Antihistamines, Corticosteroids, Antigonadotropic agents, and Vasopressor. In terms of end use, angioedema treatment market is classified into Hospitals, Clinics, and Research Organizations. Regionally, the angioedema treatment industry is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.

Insights into the Antihistamines Drug Class Segment

Angioedema Treatment Market Analysis By Drug Class

The antihistamines segment is projected to hold 33.2% of the angioedema treatment market revenue share in 2025, making it the leading drug class. This position is supported by the segment’s effectiveness in controlling histamine-mediated angioedema, particularly in cases linked to allergic reactions and idiopathic conditions. Antihistamines are widely preferred due to their rapid onset of action, favorable safety profile, and availability in both oral and injectable formulations.

The cost-effectiveness of antihistamines compared to other therapeutic options has reinforced their widespread adoption across both developed and emerging markets. Increased accessibility through over-the-counter availability and hospital pharmacies further contributes to the segment’s leadership.

Ongoing improvements in second- and third-generation antihistamines, offering reduced sedative effects and longer durations of action, are also enhancing their clinical utility As awareness of angioedema management grows and the need for immediate intervention remains critical, the antihistamines segment is expected to sustain its dominant share, supported by both clinical efficacy and strong market availability.

Insights into the Hospitals End Use Segment

Angioedema Treatment Market Analysis By End Use

The hospitals segment is anticipated to account for 52.3% of the angioedema treatment market revenue share in 2025, positioning it as the leading end-use setting. This dominance is being driven by the high frequency of patients presenting to hospitals for emergency care during acute angioedema episodes, which often require immediate medical intervention. Hospitals are equipped with advanced diagnostic and therapeutic resources, including access to intensive care units and specialized drugs, which makes them the preferred setting for treatment.

Growing reliance on hospital-based care is also reinforced by the need for rapid administration of intravenous therapies and continuous monitoring in severe cases. Additionally, hospitals are central hubs for clinical trials and specialist consultations, which enhances their role in patient management.

The expansion of healthcare infrastructure, particularly in emerging economies, is increasing hospital capacity and accessibility, further supporting the segment’s share As awareness and diagnosis rates improve globally, hospitals are expected to remain the dominant channel for angioedema treatment, ensuring patient safety and effective outcomes.

Market Overview

Angioedema Treatment Market Outlook 2025 - 2035

Healthcare systems around the world are adopting the latest medical technology involving angioedema treatment solutions. The increasing geriatric population is also attributed to abnormal lifestyles and unhealthy eating habits. Furthermore, the rising cases of hereditary angioedema, along with the disorders related to it, such as appendicitis, and gastrointestinal issues, are fueling the sales of angioedema treatment solutions.

Majorly treated with medication, the rising cases of allergic angioedema and idiopathic angioedema fuel the sales of angioedema treatment solutions. The government invests in research and development programs. The higher cases of angioedema in developed nations such as the US and the UK are gaining traction in the angioedema treatment market.

Development of Novel Drugs Spice Up the Growth for Manufacturers

Pharmaceuticals and research organizations work to process novel drugs and supportive treatments for angioedema. These medications improve medical facilities and health insurance along with advanced technology. Thus the market for angioedema treatment will boost in the coming years. The higher awareness of the disease and its complications has made people take the treatment seriously, adopting the angioedema treatment solutions.

Advanced technology states that swelling in hereditary angioedema patients is easily controlled with CRISPR treatment. The newly found CRISPR genome editing technology reduces the frequency of attacks in hereditary angioedema patients. Thus, the high-end research programs launched by governments and private entities help the market for angioedema treatment.

The primary treatment of ACEI-AAE is, first and foremost, discontinuation of the inciting drug and management of the airway. The resolution period lies between 24-72 hours. The rising demand for antihistamines, epinephrine, and steroids is to their requirements in different cases of angioedema. The increased involvement of healthcare facilities in dealing with mid-level diseases faster so that the maximum resources can be saved for chronic diseases fuels the market growth for angioedema treatments.

Allergies affect about 30% of the adults and 40% of children and are increasing day by day. It is the fifth leading cause of chronic diseases affecting approximately 50 million people in the United States. Angioedema is one of the common condition caused due to allergies and show sudden swelling under the skin surface.

It is also sad to be the most dangerous form of hives and can affect hands, feet, lips, eye lids and genitals. There are four different types of angioedema as allergic angioedema, idiopathic angioedema, drug-induced angioedema and hereditary angioedema.

The treatment of angioedema may include a normal physical examination, even though with proper medication angioedema cannot be completely cured but regular drugs can help in preventing the attacks in the patients. Allergic angioedema and idiopathic angioedema can be treated using combination drugs and helped relieving swelling. In case of severe cases of angioedema steroid injections may be needed.

In the United States it was reported that in 2010 the total spending on allergies was US$ 17.5 billion from which food allergies cost about US$ 25 million, thus people having severe allergies and changing life-style can be the major factors contributing the growth of the angioedema treatment market.

The increasing rate of angioedema in the United States and other regions has triggered the demand for hospitalization and advancements in the treatment of angioedema. Though angioedema can be treated, it cannot be completely cured and rapidly increasing allergic conditions can give rise to epidemiology, such factors are responsible for hindering the growth of the market. The crucial challenge for the pharmaceuticals is enhance and advance the treatment for angioedema and come up with better drugs.

Globally the number of allergies and allergy conditions as angioedema are rapidly increasing, thus the angioedema treatment market is estimated to have an enormous growth during the forecast period (2025-2026). Pharmaceuticals and research organizations are working to develop novel drug and treatments for angioedema. Improving medical facilities and health insurances along with advance technology the market for angioedema treatment will boost in coming years.

On the basis of region presence, Angioedema Treatment market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Currently, North America dominates the global market for Angioedema Treatment due to high prevalence rate of sinusitis, followed by Europe. According to the epidemiology took place in America in 2010 had increased the hospitalization rate and increasing allergies in adults and children have triggered the growth rate of angioedema. However factors such as climatic conditions inappropriate for angioedema patients and lack of awareness among people about angioedema will hamper the market growth in regions like Asia-pacific and RoW.

Treatment of Drug-Induced Angioedema Gains Traction in the Market

The rising cases of drug-induced angioedema due to the increased application of drugs among all generations adds new elements to the angioedema treatment process. The additions involve the usage of alternative medication and symptoms-based treatment. Furthermore, the increased usage of drugs in the US has pushed healthcare services to focus on minimizing the swelling of the eyes, lips, genitals, hands, and feet. Drug-infused angioedema is diagnosed through blood and allergy tests that determine the type of angioedema.

The report covers exhaustive analysis on

  • Angioedema Treatment Market Segments
  • Angioedema Treatment Market Dynamics
  • Historical Actual Market Size, 2025 - 2025
  • Angioedema Treatment Market Size & Forecast 2025 to 2026
  • Angioedema Treatment Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Angioedema Treatment Drivers and Restraints

Regional analysis includes

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Analysis of Angioedema Treatment Market By Key Countries

Angioedema Treatment Market Cagr Analysis By Country

Country CAGR
China 22.4%
India 20.8%
Germany 19.1%
France 17.4%
UK 15.8%
USA 14.1%
Brazil 12.5%

Country-wise Analysis

The Angioedema Treatment Market is expected to register a CAGR of 16.6% during the forecast period, exhibiting varied country level momentum. China leads with the highest CAGR of 22.4%, followed by India at 20.8%. Developed markets such as Germany, France, and the UK continue to expand steadily, while the USA is likely to grow at consistent rates. Brazil posts the lowest CAGR at 12.5%, yet still underscores a broadly positive trajectory for the global Angioedema Treatment Market. In 2024, Germany held a dominant revenue in the Western Europe market and is expected to grow with a CAGR of 19.1%. The USA  Angioedema Treatment Market is estimated to be valued at USD 2.5 billion in 2025 and is anticipated to reach a valuation of USD 9.2 billion by 2035. Sales are projected to rise at a CAGR of 14.1% over the forecast period between 2025 and 2035. While Japan and South Korea markets are estimated to be valued at USD 349.5 million and USD 195.8 million respectively in 2025.

Key Players in the Angioedema Treatment Market

Angioedema Treatment Market Analysis By Company
  • Shire plc.
  • CSL Limited
  • Pharming Group NV
  • Ionis Pharmaceuticals, Inc.
  • iBio Inc.
  • BioCryst Pharmaceuticals, Inc.

Scope of the Report

Item Value
Quantitative Units USD 6.5 Billion
Drug Class Antihistamines, Corticosteroids, Antigonadotropic agents, and Vasopressor
End Use Hospitals, Clinics, and Research Organizations
Regions Covered North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country Covered United States, Canada, Germany, France, United Kingdom, China, Japan, India, Brazil, South Africa
Key Companies Profiled Shire plc., CSL Limited, Pharming Group NV, Ionis Pharmaceuticals, Inc., iBio Inc., and BioCryst Pharmaceuticals, Inc.

Angioedema Treatment Market by Segments

Drug Class:

  • Antihistamines
  • Corticosteroids
  • Antigonadotropic agents
  • Vasopressor

End Use:

  • Hospitals
  • Clinics
  • Research Organizations

Region:

  • North America
    • USA
    • Canada
    • Mexico
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Western Europe
    • Germany
    • UK
    • Italy
    • Spain
    • France
    • Nordic
    • BENELUX
    • Rest of Western Europe
  • Eastern Europe
    • Russia
    • Poland
    • Hungary
    • Balkan & Baltic
    • Rest of Eastern Europe
  • East Asia
    • China
    • Japan
    • South Korea
  • South Asia and Pacific
    • India
    • ASEAN
    • Australia & New Zealand
    • Rest of South Asia and Pacific
  • Middle East & Africa
    • Kingdom of Saudi Arabia
    • Other GCC Countries
    • Turkiye
    • South Africa
    • Other African Union
    • Rest of Middle East & Africa

Table of Content

  1. Executive Summary
    • Global Market Outlook
    • Demand-side Trends
    • Supply-side Trends
    • Technology Roadmap Analysis
    • Analysis and Recommendations
  2. Market Overview
    • Market Coverage / Taxonomy
    • Market Definition / Scope / Limitations
  3. Market Background
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunity
      • Trends
    • Scenario Forecast
      • Demand in Optimistic Scenario
      • Demand in Likely Scenario
      • Demand in Conservative Scenario
    • Opportunity Map Analysis
    • Product Life Cycle Analysis
    • Supply Chain Analysis
    • Investment Feasibility Matrix
    • Value Chain Analysis
    • PESTLE and Porter’s Analysis
    • Regulatory Landscape
    • Regional Parent Market Outlook
    • Production and Consumption Statistics
    • Import and Export Statistics
  4. Global Market Analysis 2020 to 2024 and Forecast, 2025 to 2035
    • Historical Market Size Value (USD Million) Analysis, 2020 to 2024
    • Current and Future Market Size Value (USD Million) Projections, 2025 to 2035
      • Y-o-Y Growth Trend Analysis
      • Absolute $ Opportunity Analysis
  5. Global Market Pricing Analysis 2020 to 2024 and Forecast 2025 to 2035
  6. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Drug Class
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Drug Class , 2020 to 2024
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Drug Class , 2025 to 2035
      • Antihistamines
      • Corticosteroids
      • Antigonadotropic agents
      • Vasopressor
    • Y-o-Y Growth Trend Analysis By Drug Class , 2020 to 2024
    • Absolute $ Opportunity Analysis By Drug Class , 2025 to 2035
  7. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By End Use
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By End Use, 2020 to 2024
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By End Use, 2025 to 2035
      • Hospitals
      • Clinics
      • Research Organizations
    • Y-o-Y Growth Trend Analysis By End Use, 2020 to 2024
    • Absolute $ Opportunity Analysis By End Use, 2025 to 2035
  8. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Region
    • Introduction
    • Historical Market Size Value (USD Million) Analysis By Region, 2020 to 2024
    • Current Market Size Value (USD Million) Analysis and Forecast By Region, 2025 to 2035
      • North America
      • Latin America
      • Western Europe
      • Eastern Europe
      • East Asia
      • South Asia and Pacific
      • Middle East & Africa
    • Market Attractiveness Analysis By Region
  9. North America Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2024
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
      • By Country
        • USA
        • Canada
        • Mexico
      • By Drug Class
      • By End Use
    • Market Attractiveness Analysis
      • By Country
      • By Drug Class
      • By End Use
    • Key Takeaways
  10. Latin America Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2024
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
      • By Country
        • Brazil
        • Chile
        • Rest of Latin America
      • By Drug Class
      • By End Use
    • Market Attractiveness Analysis
      • By Country
      • By Drug Class
      • By End Use
    • Key Takeaways
  11. Western Europe Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2024
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
      • By Country
        • Germany
        • UK
        • Italy
        • Spain
        • France
        • Nordic
        • BENELUX
        • Rest of Western Europe
      • By Drug Class
      • By End Use
    • Market Attractiveness Analysis
      • By Country
      • By Drug Class
      • By End Use
    • Key Takeaways
  12. Eastern Europe Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2024
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
      • By Country
        • Russia
        • Poland
        • Hungary
        • Balkan & Baltic
        • Rest of Eastern Europe
      • By Drug Class
      • By End Use
    • Market Attractiveness Analysis
      • By Country
      • By Drug Class
      • By End Use
    • Key Takeaways
  13. East Asia Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2024
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
      • By Country
        • China
        • Japan
        • South Korea
      • By Drug Class
      • By End Use
    • Market Attractiveness Analysis
      • By Country
      • By Drug Class
      • By End Use
    • Key Takeaways
  14. South Asia and Pacific Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2024
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
      • By Country
        • India
        • ASEAN
        • Australia & New Zealand
        • Rest of South Asia and Pacific
      • By Drug Class
      • By End Use
    • Market Attractiveness Analysis
      • By Country
      • By Drug Class
      • By End Use
    • Key Takeaways
  15. Middle East & Africa Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2024
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
      • By Country
        • Kingdom of Saudi Arabia
        • Other GCC Countries
        • Turkiye
        • South Africa
        • Other African Union
        • Rest of Middle East & Africa
      • By Drug Class
      • By End Use
    • Market Attractiveness Analysis
      • By Country
      • By Drug Class
      • By End Use
    • Key Takeaways
  16. Key Countries Market Analysis
    • USA
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Drug Class
        • By End Use
    • Canada
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Drug Class
        • By End Use
    • Mexico
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Drug Class
        • By End Use
    • Brazil
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Drug Class
        • By End Use
    • Chile
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Drug Class
        • By End Use
    • Germany
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Drug Class
        • By End Use
    • UK
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Drug Class
        • By End Use
    • Italy
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Drug Class
        • By End Use
    • Spain
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Drug Class
        • By End Use
    • France
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Drug Class
        • By End Use
    • India
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Drug Class
        • By End Use
    • ASEAN
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Drug Class
        • By End Use
    • Australia & New Zealand
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Drug Class
        • By End Use
    • China
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Drug Class
        • By End Use
    • Japan
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Drug Class
        • By End Use
    • South Korea
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Drug Class
        • By End Use
    • Russia
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Drug Class
        • By End Use
    • Poland
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Drug Class
        • By End Use
    • Hungary
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Drug Class
        • By End Use
    • Kingdom of Saudi Arabia
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Drug Class
        • By End Use
    • Turkiye
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Drug Class
        • By End Use
    • South Africa
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Drug Class
        • By End Use
  17. Market Structure Analysis
    • Competition Dashboard
    • Competition Benchmarking
    • Market Share Analysis of Top Players
      • By Regional
      • By Drug Class
      • By End Use
  18. Competition Analysis
    • Competition Deep Dive
      • Shire plc.
        • Overview
        • Product Portfolio
        • Profitability by Market Segments (Product/Age /Sales Channel/Region)
        • Sales Footprint
        • Strategy Overview
          • Marketing Strategy
          • Product Strategy
          • Channel Strategy
      • CSL Limited
      • Pharming Group NV
      • Ionis Pharmaceuticals, Inc.
      • iBio Inc.
      • BioCryst Pharmaceuticals, Inc.
  19. Assumptions & Acronyms Used
  20. Research Methodology

List of Tables

  • Table 1: Global Market Value (USD Million) Forecast by Region, 2020-2035
  • Table 2: Global Market Value (USD Million) Forecast by Drug Class , 2020-2035
  • Table 3: Global Market Value (USD Million) Forecast by End Use, 2020-2035
  • Table 4: North America Market Value (USD Million) Forecast by Country, 2020-2035
  • Table 5: North America Market Value (USD Million) Forecast by Drug Class , 2020-2035
  • Table 6: North America Market Value (USD Million) Forecast by End Use, 2020-2035
  • Table 7: Latin America Market Value (USD Million) Forecast by Country, 2020-2035
  • Table 8: Latin America Market Value (USD Million) Forecast by Drug Class , 2020-2035
  • Table 9: Latin America Market Value (USD Million) Forecast by End Use, 2020-2035
  • Table 10: Western Europe Market Value (USD Million) Forecast by Country, 2020-2035
  • Table 11: Western Europe Market Value (USD Million) Forecast by Drug Class , 2020-2035
  • Table 12: Western Europe Market Value (USD Million) Forecast by End Use, 2020-2035
  • Table 13: Eastern Europe Market Value (USD Million) Forecast by Country, 2020-2035
  • Table 14: Eastern Europe Market Value (USD Million) Forecast by Drug Class , 2020-2035
  • Table 15: Eastern Europe Market Value (USD Million) Forecast by End Use, 2020-2035
  • Table 16: East Asia Market Value (USD Million) Forecast by Country, 2020-2035
  • Table 17: East Asia Market Value (USD Million) Forecast by Drug Class , 2020-2035
  • Table 18: East Asia Market Value (USD Million) Forecast by End Use, 2020-2035
  • Table 19: South Asia and Pacific Market Value (USD Million) Forecast by Country, 2020-2035
  • Table 20: South Asia and Pacific Market Value (USD Million) Forecast by Drug Class , 2020-2035
  • Table 21: South Asia and Pacific Market Value (USD Million) Forecast by End Use, 2020-2035
  • Table 22: Middle East & Africa Market Value (USD Million) Forecast by Country, 2020-2035
  • Table 23: Middle East & Africa Market Value (USD Million) Forecast by Drug Class , 2020-2035
  • Table 24: Middle East & Africa Market Value (USD Million) Forecast by End Use, 2020-2035

List of Figures

  • Figure 1: Global Market Pricing Analysis
  • Figure 2: Global Market Value (USD Million) Forecast 2020-2035
  • Figure 3: Global Market Value (USD Million) Share and BPS Analysis by Region, 2025 and 2035
  • Figure 4: Global Market Y-o-Y Growth Comparison by Region, 2025-2035
  • Figure 5: Global Market Attractiveness Analysis by Region
  • Figure 6: North America Market Incremental Dollar Opportunity, 2025-2035
  • Figure 7: Latin America Market Incremental Dollar Opportunity, 2025-2035
  • Figure 8: Western Europe Market Incremental Dollar Opportunity, 2025-2035
  • Figure 9: Eastern Europe Market Incremental Dollar Opportunity, 2025-2035
  • Figure 10: East Asia Market Incremental Dollar Opportunity, 2025-2035
  • Figure 11: South Asia and Pacific Market Incremental Dollar Opportunity, 2025-2035
  • Figure 12: Middle East & Africa Market Incremental Dollar Opportunity, 2025-2035
  • Figure 13: North America Market Value Share and BPS Analysis by Country, 2025 and 2035
  • Figure 14: Latin America Market Value Share and BPS Analysis by Country, 2025 and 2035
  • Figure 15: Western Europe Market Value Share and BPS Analysis by Country, 2025 and 2035
  • Figure 16: Eastern Europe Market Value Share and BPS Analysis by Country, 2025 and 2035
  • Figure 17: East Asia Market Value Share and BPS Analysis by Country, 2025 and 2035
  • Figure 18: South Asia and Pacific Market Value Share and BPS Analysis by Country, 2025 and 2035
  • Figure 19: Middle East & Africa Market Value Share and BPS Analysis by Country, 2025 and 2035
  • Figure 20: Global Market - Tier Structure Analysis
  • Figure 21: Global Market - Company Share Analysis

Frequently Asked Questions

How big is the angioedema treatment market in 2025?

The global angioedema treatment market is estimated to be valued at USD 6.5 billion in 2025.

What will be the size of angioedema treatment market in 2035?

The market size for the angioedema treatment market is projected to reach USD 30.3 billion by 2035.

How much will be the angioedema treatment market growth between 2025 and 2035?

The angioedema treatment market is expected to grow at a 16.6% CAGR between 2025 and 2035.

What are the key product types in the angioedema treatment market?

The key product types in angioedema treatment market are antihistamines, corticosteroids, antigonadotropic agents and vasopressor.

Which end use segment to contribute significant share in the angioedema treatment market in 2025?

In terms of end use, hospitals segment to command 52.3% share in the angioedema treatment market in 2025.

Explore Similar Insights

Future Market Insights

Angioedema Treatment Market

Chat With

MaRIA

Hi There, I am MaRIA, Your Market Research Intelligence Assistant. How may I help you?